ENRICHMENT OF IN VIVO EFFICACY OF CATECHIN RICH EXTRACT WITH THE APPLICATION OF NANOTECHNOLOGY
Objective: The primary goal of this study was to convert a natural catechin-rich extract into nanoparticles by using a biodegradable and non-toxic polymer Eudragit L 100 to address the various biopharmaceutical problems of catechin.
Methods: Nanoparticles were prepared by emulsion solvent evaporation technique using Eudragit L 100 in increasing concentration. Optimization of processing conditions like a selection of organic solvents, diluent and surfactant concentrations, drug and polymer ratio and method of drying to increase the biological efficiency were duly attempted. Parameters such as dynamic light scattering, zeta potential, SEM and energy-dispersive X-ray spectroscopy were assessed for the evaluation of nanoparticles.
Results: The entrapment efficiency was found to be between 35-45 % with methanol compared to other organic solvents. The zeta potential values of all the formulations were in the range ofÂ±30 mV toÂ±60 mV) which confirms moderate to good stability. A rapid or â€˜burstâ€™ effect of the drug release in pH 6.8 buffer showing 92 % in the first 30 min which gradually decreased to 52 % by the end of 180 min but in the pH 7.4, the release was found to be moderate. SEM and DLS indicated particles were of spherical shape lying in a nanometer range of 100 to 200 nm with a proportional influence of polymer on the particles size.Conclusion: Nanoformulations were found to be more stable and confirmed the presence of major elements such as carbon and oxygen. The findings collectively indicate that it may be worthwhile to apply nanotechnology for the design of an advanced oral dosage form for an enhanced bioavailability and biological efficacy.
2. Chidambara Murthy KN, Kim J, Vikram A, Patil BS. Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chem 2012;132:27-34.
3. Agrawal AD. Pharmacological activities of flavonoids: a review. Int J Pharma Sci Nanotech 2011;4:1394-8.
4. Vanna Sanna, Imtiaz, Siddiqui A, Mario Sechi, Hasan Mukhtar. Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Lett 2013;334:142â€“51.
5. Gupta RM, Ramteke PW. Antimicrobial activity of Emblica officinalis, Saracaindica and Terminalia arjuna against multi-drug resistant (MDR) bacterial pathogens, hacettepe. J Bio Chem 2011;39:435â€“7.
6. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK. (âˆ’)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024â€“9.
7. Fraga Cesar G, Oteiza Patricia I. Dietary flavanoids: the role of (-)-epicatechin and related procyanidins in cell signalling. J Free Radical Bio Med 2011;51:813-23.
8. Zhu Min, Chen Yu, Ronald C Li. Oral absorption and bioavailability of tea catechin. Plant Med 2000;66:444-7.
9. Kohri T, Nanjo F, Suzuki M. Synthesis of (-) [4-3H] epi-gallocatechin gallate and its metabolic fate in rats after intravenous administration. J Agric Food Chem 2001; 49:1042â€“8.
10. Tasnima Khushnud, Shaker A, Mousa. Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer. Mol Biotech 2013;55:78â€“86.
11. McNeil SE. Nanotechnology for the biologist. J Leukocyte Bio 2005;78:585-94.
12. AdlinJino Nesalin J, Anton Smith A. Preparation and evaluation of chitosan nanoparticles containing zidovudine. Asian J Pharma Sci 2012;7:80-4.
13. Ashwini Kumar. Enhancement of solubility and dissolution rate of Irbesartan by solid dispersion technique. Asian J Pharm Clini Res 2011;4:36-Â¬40.
14. Prasanna Lakshmi, Giddam Ashwini Kumar. NanoÂ¬suspension technology: a teview. Int J Pharm Pharm Sci 2010;2:35-40.
15. Monika P, Ahalya N, Basavaraj BV, Chidambara Murthy KN. Development and characterization of catechin-rich extract nanoparticles. Int Rev Appl Biotech Biochem 2014;2:85-93.
16. Jai Prakash B, Gaja, Sayyad FJ. Preparation and evaluation of nanodispersions of telmisartan by various techniques. Inventi Impact NDD 2013;2:151-9.
17. Nagavarma BVN, Hemant KS Yadav, Ayaz A, Vasudha LS, Shivakumar HG. Different techniques for preparation of polymeric nanoparticles-a review. Asian J Pharm Clin Res 2012;5:16-23.
18. Zu Y, Wang D, Zhao X, Jiang R, Zhang Q, Zhao D. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles. Int J Mol Sci 2011;12:4237â€“49.
19. Kunal A Gaidhani, Mallinath Harwalkar, Deepak Bhambere, Pallavi S Nirgude. Lyophilization/Freeze dryingâ€“a review. Int J Novel Trends Pharm Sci 2015;4:516-43.
20. Bharathi M, Sarat Chandra Prasad M, Latha Eswari R, Wasim Raja S, Ravi Teja Allena, Brito Raj S. Preparation and in vitro andin vivo characterization of valsartan loaded eudragit nanoparticles. Der Pharm Sin 2012;3:516-25.
21. Momin Mohammed, Abdul Motalib, Afrose Afgrina, Khan Mohammed Salahuddin, Mashud SM. Method validation for the determination of water content of metered dose inhaler by Karl Fischer coulometer. Int Res J Phar 2012;3:144-7.
22. Hu Daode, Liu Liang, Chen Wenjuan, Li Sining, Zhao Yaping. A novel preparation method for 5-aminosalicylic acid loaded eudragit S100 nanoparticles. Int J Mol Sci 2012;13:6454-68.
23. Sudheer Nadendh, Snehalatha, Nagaraja TS, Bharathi. Effect of various polymers on swelling and in vitro release of rampril in the effervescent system. Int J Pharm Life Sci 2013;4:2621-5.
24. Kalam MA, Humayun M, Parvez N, Yadav S Garga. Release kinetics of modified pharmaceutical dosage forms: a review. Cont J Pharm Sci 2007;1:30-5.
25. Sharma A, Shukla T, Indira M. Design, development and evaluation of aceclofenac sustained release matrix tablet. Int J Drug Res 2011;3:307â€“12.
26. Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excep Food Chem 2010;1:3â€“26.
27. Ahmed M Samy, Afaf A, Ramadan, Amal SM. Abu el-enin, Yasmin IM Mortagi. Formulation and optimization of itraconazole pro-niosomes using box behnken design. Int J Appl Pharm 2018;10:41-51.